Compare NVEC & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NVEC | SIGA |
|---|---|---|
| Founded | 1989 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 398.4M | 341.0M |
| IPO Year | 1995 | 2016 |
| Metric | NVEC | SIGA |
|---|---|---|
| Price | $85.74 | $4.67 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 58.7K | ★ 517.0K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | 5.13% | ★ 13.24% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 2.12 | 0.32 |
| Revenue | ★ $25,874,694.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $224.81 |
| P/E Ratio | $39.67 | ★ $14.44 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $57.21 | $4.29 |
| 52 Week High | $88.86 | $9.62 |
| Indicator | NVEC | SIGA |
|---|---|---|
| Relative Strength Index (RSI) | 62.81 | 45.72 |
| Support Level | $64.17 | $4.29 |
| Resistance Level | N/A | $4.80 |
| Average True Range (ATR) | 4.23 | 0.12 |
| MACD | 0.20 | 0.06 |
| Stochastic Oscillator | 76.48 | 66.67 |
NVE Corp develops and sells devices that use spintronics, a nanotechnology that relies on electron spin. It manufactures high-performance spintronic products including sensors and couplers that are used to acquire and transmit data. The company's products include Digital sensors, Medical sensors, Rotation Sensors, GT Sensors, Angle Sensors, Analog sensors, MSOP Isolators, Passive-In Transceivers, and others. The company manufactures high-performance spintronic products including sensors and couplers. The company's designs are based on giant magnetoresistance GMR and tunneling magnetoresistance TMR combined with integrated circuitry.
SIGA Technologies Inc a commercial-stage pharmaceutical company. The Company sells its product, TPOX oral TPOXX, also known as tecovirimat, Tecovirimat-SIGA, or TEPOXX (tecovirimat) in certain international markets, to the U.S. Government and international governments (including government-affiliated entities). The Company operates in one single operating and reportable segment, which includes all activities related to the sale of the Company's Oral and IV TPOXX as well as research and development services.